Skip to content
Medxy AI
  • Wellness & Lifestyle
  • Clinical Updates
  • Medical News
  • Wellness & Lifestyle
  • Clinical Updates
  • Medical News
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
Subscribe
  • Home
  • semaglutide
Advances in Obesity and Diabetes Management: Highlights from ADA 2025
Posted inClinical Updates Medical News Wellness & Lifestyle

Advances in Obesity and Diabetes Management: Highlights from ADA 2025

Posted by By MedXY 07/31/2025
New weight-loss drug combinations, oral semaglutide cardiovascular outcomes, inhaled insulin for type 1 diabetes, and benefits of switching from diet drinks to water were key ADA 2025 findings.
Read More
The Rise of Ozempic and Wegovy: Revolutionizing Weight Loss, But At What Cost?
Posted inWellness & Lifestyle

The Rise of Ozempic and Wegovy: Revolutionizing Weight Loss, But At What Cost?

Posted by By MedXY 07/28/2025
Semaglutide drugs like Ozempic and Wegovy are transforming obesity treatment, but questions remain about long-term safety, access, and societal impact.
Read More
Ozempic and the Weight Loss Revolution: Miracle Drug or Medical Hype?
Posted inWellness & Lifestyle

Ozempic and the Weight Loss Revolution: Miracle Drug or Medical Hype?

Posted by By MedXY 07/28/2025
Exploring the science, benefits, risks, and realities behind Ozempic and other GLP-1 drugs in the fight against obesity.
Read More
Posted inWellness & Lifestyle

The End of the Diet? Inside the Game-Changing Anti-Obesity Drug Revolution

Posted by By MedXY 07/25/2025
New anti-obesity medications are transforming weight management, challenging old paradigms, and raising new questions about the future of dieting and health.
Read More
  • Sotatercept in High-Risk Pulmonary Arterial Hypertension: A Landmark Advance in Patient Outcomes
  • Upadacitinib and Janus Kinase Inhibitors in Giant-Cell Arteritis: Clinical Trial and Real-World Evidence
  • Navigational Bronchoscopy Versus Transthoracic Needle Biopsy for Peripheral Lung Nodules: New Evidence from the VERITAS Trial
  • Regional Nodal Irradiation After Neoadjuvant Chemotherapy: Is Omission Safe for Breast Cancer Patients with ypN0 Status?
  • Trimethoprim–Sulfamethoxazole in Pregnancy: No Impact on Birth Weight in a Zimbabwean RCT
  • About us
  • Contact us
  • Privacy Policy
  • Subscribe Now!

  • English
  • 日本語
  • Tiếng Việt
  • 中文

aging Alzheimer's disease Antibiotics breast cancer clinical trial clinical trials diabetes diagnosis diet epidemiology FDA FDA approval GLP-1 health healthcare Hypertension immunotherapy infectious disease lifestyle lifestyle intervention longevity maternal health men's health Menopause mental health nutrition obesity older adults PCOS Physical Activity Pregnancy prevention probiotics public health randomized trial semaglutide sexual health sleep stroke treatment Vaccine walking weight loss wellness women's health

Your health, we care

Copyright 2025 — Medxy AI. All rights reserved.
Scroll to Top